Implication of IRF4 Aberrant Gene Expression in the Acute Leukemias of Childhood

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Adamaki, Maria ^a   Lambrou, George I ^a   Athanasiadou, Anastasia ^a   Tzanoudaki, Marianna ^b   Vlahopoulos, Spiros ^a   Moschovi, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; B LYMPHOCYTE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL MATURATION; CELL POPULATION; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IRF4 GENE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRE B LYMPHOCYTE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; B CELL LEUKEMIA; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; INFANT; MORTALITY; NEWBORN; PATHOLOGY; RECURRENT DISEASE; SURVIVAL; T CELL LEUKEMIA; TUMOR CELL LINE;

INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4;

ADOLESCENT; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON REGULATORY FACTORS; LEUKEMIA, B-CELL; LEUKEMIA, T-CELL; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; SURVIVAL ANALYSIS;

EID: 84881568102     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072326     Document Type: Article

References (51)

1. Pui CH, Relling MV, Downing JR, (2004) Acute lymphoblastic leukemia. N Engl J Med 350: 1535-1548.
2. Petridou ET, Dimitrova N, Eser S, Kachanov D, Karakilinc H, et al. (2013) Childhood leukemia and lymphoma: time trends and factors affecting survival in five Southern and Eastern European Cancer Registries. Cancer Causes Control 24: 1111-1118.
3. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, et al. (2006) Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442: 818-822.
4. Armstrong SA, Golub TR, Korsmeyer SJ, (2003) MLL-rearranged leukemias: insights from gene expression profiling. Semin Hematol 40: 268-273.
5. Boiers C, Buza-Vidas N, Jensen CT, Pronk CJ, Kharazi S, et al. (2010) Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development. Blood 115: 5061-5068.
6. Tsutsumi S, Taketani T, Nishimura K, Ge X, Taki T, et al. (2003) Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res 63: 4882-4887.
7. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, et al. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1: 133-143.
8. Ayton PM, Cleary ML, (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 17: 2298-2307.
9. Sitwala KV, Dandekar MN, Hess JL, (2008) HOX proteins and leukemia. Int J Clin Exp Pathol 1: 461-474.
10. Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, et al. (2008) MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Leukemia 22: 66-77.
11. Busslinger M, (2004) Transcriptional control of early B cell development. Annu Rev Immunol 22: 55-79.
12. Lu R, (2008) Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol 29: 487-492.
13. De Silva NS, Simonetti G, Heise N, Klein U, (2012) The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol Rev 247: 73-92.
14. Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, et al. (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275: 540-543.
15. Gupta S, Jiang M, Anthony A, Pernis AB, (1999) Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J Exp Med 190: 1837-1848.
16. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, et al. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7: 773-782.
17. Shaffer AL, Emre NC, Romesser PB, Staudt LM, (2009) IRF4: Immunity. Malignancy! Therapy? Clin Cancer Res 15: 2954-2961.
18. Grumont RJ, Gerondakis S, (2000) Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med 191: 1281-1292.
19. Acquaviva J, Chen X, Ren R, (2008) IRF-4 functions as a tumor suppressor in early B-cell development. Blood 112: 3798-3806.
20. Yoshida S, Nakazawa N, Iida S, Hayami Y, Sato S, et al. (1999) Detection of MUM1/IRF4-IgH fusion in multiple myeloma. Leukemia 13: 1812-1816.
21. Yamagata T, Nishida J, Tanaka S, Sakai R, Mitani K, et al. (1996) A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol 16: 1283-1294.
22. Pham-Ledard A, Prochazkova-Carlotti M, Laharanne E, Vergier B, Jouary T, et al. (2009) IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases. J Invest Dermatol 130: 816-825.
23. Bisig B, Gaulard P, de Leval L, (2012) New biomarkers in T-cell lymphomas. Best Pract Res Clin Haematol 25: 13-28.
24. Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, et al. (2002) Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood 100: 4671-4675.
25. Ito M, Iida S, Inagaki H, Tsuboi K, Komatsu H, et al. (2002) MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Jpn J Cancer Res 93: 685-694.
26. Craig F, Soma L, Melan M, Kant J, Swerdlow S, (2008) MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia. Leuk Lymphoma 49: 273-280.
27. Allan JM, Sunter NJ, Bailey JR, Pettitt AR, Harris RJ, et al. (2010) Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia. Leukemia 24: 877-881.
28. le Viseur C, Hotfilder M, Bomken S, Wilson K, Rottgers S, et al. (2008) In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 14: 47-58.
29. Do TN, Ucisik-Akkaya E, Davis CF, Morrison BA, Dorak MT, (2010) An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Biochim Biophys Acta 1802: 292-300.
30. Lambrou GI, Vlahopoulos S, Papathanasiou C, Papanikolaou M, Karpusas M, et al. (2009) Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression. Leuk Res.
31. Uckun FM, Gaynon P, Sather H, Arthur D, Trigg M, et al. (1997) Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 89: 2488-2493.
32. Pui CH, Behm FG, Crist WM, (1993) Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82: 343-362.
33. Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, et al. (2010) Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol 11: 429-438.
34. Schmidt M, Hochhaus A, Konig-Merediz SA, Brendel C, Proba J, et al. (2000) Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. J Clin Oncol 18: 3331-3338.
35. Brass AL, Kehrli E, Eisenbeis CF, Storb U, Singh H, (1996) Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev 10: 2335-2347.
36. Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, et al. (2006) Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25: 225-236.
37. PubMed website. Available: http://www.ncbi.nlm.nih.gov/geo/tools/profileGraph.cgi? ID = GDS1095:37625/Accessed 2013 May 5.
38. Kanno Y, Levi BZ, Tamura T, Ozato K, (2005) Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J Interferon Cytokine Res 25: 770-779.
39. Gabriele L, Ozato K, (2007) The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev 18: 503-510.
40. Lehtonen A, Veckman V, Nikula T, Lahesmaa R, Kinnunen L, et al. (2005) Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J Immunol 175: 6570-6579.
41. Yamamoto M, Kato T, Hotta C, Nishiyama A, Kurotaki D, et al. (2011) Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One 6: e25812.
42. Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, et al. (1998) Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91: 22-29.
43. Schmidt M, Hochhaus A, Nitsche A, Hehlmann R, Neubauer A, (2001) Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha. Blood 97: 3648-3650.
44. Pernis AB, (2002) The role of IRF-4 in B and T cell activation and differentiation. J Interferon Cytokine Res 22: 111-120.
45. Garcia JF, Roncador G, Garcia JF, Sanz AI, Maestre L, et al. (2006) PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica 91: 467-474.
46. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, et al. (2009) Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
47. Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, et al. (2008) IRF4 addiction in multiple myeloma. Nature 454: 226-231.
48. Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, et al. (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95: 2084-2092.
49. Lohoff M, Mittrucker HW, Brustle A, Sommer F, Casper B, et al. (2004) Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells. J Exp Med 200: 247-253.
50. Lee CH, Melchers M, Wang H, Torrey TA, Slota R, et al. (2006) Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med 203: 63-72.
51. Saito M, Gao J, Basso K, Kitagawa Y, Smith PM, et al. (2007) A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12: 280-292.